128 related articles for article (PubMed ID: 35956220)
1. Increased Apoptotic Activity in Low-Risk Myelodysplastic Syndrome.
Park S; Shin DY; Park JS; Park HS; Moon SY; Yoon SS; Lee DS
J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956220
[TBL] [Abstract][Full Text] [Related]
2. Replicative senescence of hematopoietic cells in patients with idiopathic cytopenia of undetermined significance.
Shin DY; Park JK; Li CC; Park HS; Moon SY; Kim SM; Im K; Chang YH; Yoon SS; Lee DS
Leuk Res; 2019 Apr; 79():22-26. PubMed ID: 30831479
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome.
Choi EJ; Cho YU; Hur EH; Park HS; Choi Y; Lee JH; Lee KH; Kim M; Hwang SH; Jang S; Park CJ; Seo EJ; Lee JH
Br J Haematol; 2022 Aug; 198(4):703-712. PubMed ID: 35612271
[TBL] [Abstract][Full Text] [Related]
4. Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
Polprasert C; Niparuck P; Rattanathammethee T; Chuncharunee S; Kobbuaklee S; Songserm K; Suksusut A; Trithiphen S; Lanamtieng T; Kongkiatkamon S; Chanswangphuwana C; Lawasut P; Bunworasate U; Rojnuckarin P
Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e293-e299. PubMed ID: 34840089
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Flow Cytometry Standardized Using the European LeukemiaNet for Myelodysplastic Syndrome.
Takeuchi A; Imataki O; Kubo H; Kondo A; Seo K; Uemura M; Yamaoka G; Murao K; Takeuchi A
Acta Haematol; 2020; 143(2):140-145. PubMed ID: 31330512
[TBL] [Abstract][Full Text] [Related]
6. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
7. Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome.
Brada SJ; van de Loosdrecht AA; Koudstaal J; de Wolf JT; Vellenga E
Leuk Res; 2004 Sep; 28(9):921-5. PubMed ID: 15234568
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome.
Petrova-Drus K; Hasserjian R; Pozdnyakova O; Dal Cin P; Mathew S; Margolskee E; Orazi A; Geyer JT
Leuk Lymphoma; 2017 Mar; 58(3):569-577. PubMed ID: 27389864
[TBL] [Abstract][Full Text] [Related]
9. ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance.
Shin DY; Park JK; Kim SM; Im K; Kim JA; Kim SY; Hwang SM; Yoon SS; Lee DS
Leuk Lymphoma; 2019 Mar; 60(3):756-763. PubMed ID: 30301403
[TBL] [Abstract][Full Text] [Related]
10. Improved risk stratification by the integration of the revised international prognostic scoring system with the myelodysplastic syndromes comorbidity index.
van Spronsen MF; Ossenkoppele GJ; Holman R; van de Loosdrecht AA
Eur J Cancer; 2014 Dec; 50(18):3198-205. PubMed ID: 25454415
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of different scoring systems and gene mutations for the prognosis of myelodysplastic syndrome (MDS) in Chinese population.
Du MY; Xu M; Deng J; Liu L; Guo T; Xia LH; Hu Y; Mei H
J Cancer; 2020; 11(2):508-519. PubMed ID: 31897246
[TBL] [Abstract][Full Text] [Related]
12. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients.
Schroeder T; Ruf L; Bernhardt A; Hildebrandt B; Aivado M; Aul C; Gattermann N; Haas R; Germing U
Ann Oncol; 2010 Nov; 21(11):2267-2271. PubMed ID: 20439346
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MCM2 in myelodysplastic syndromes: association with bone marrow cell apoptosis and peripheral cytopenia.
Suzuki S; Kurata M; Abe S; Miyazawa R; Murayama T; Hidaka M; Yamamoto K; Kitagawa M
Exp Mol Pathol; 2012 Feb; 92(1):160-6. PubMed ID: 22115939
[TBL] [Abstract][Full Text] [Related]
15. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.
Parker JE; Mufti GJ; Rasool F; Mijovic A; Devereux S; Pagliuca A
Blood; 2000 Dec; 96(12):3932-8. PubMed ID: 11090080
[TBL] [Abstract][Full Text] [Related]
16. Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register.
Moreno Berggren D; Folkvaljon Y; Engvall M; Sundberg J; Lambe M; Antunovic P; Garelius H; Lorenz F; Nilsson L; Rasmussen B; Lehmann S; Hellström-Lindberg E; Jädersten M; Ejerblad E
Br J Haematol; 2018 Jun; 181(5):614-627. PubMed ID: 29707769
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes.
Nielsen AB; Hansen JW; Ørskov AD; Dimopoulos K; Salem M; Grigorian M; Bruunsgaard H; Grønbæk K
Hemasphere; 2022 May; 6(5):e0713. PubMed ID: 35495296
[TBL] [Abstract][Full Text] [Related]
18. TET2 Expression in Bone Marrow Mononuclear Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significances.
Zhang W; Shao ZH; Fu R; Wang HQ; Li LJ; Wang J; Qu W; Liang Y; Wang GJ; Wang XM; Wu Y; Liu H; Song J; Guan J; Xing LM
Cancer Biol Med; 2012 Mar; 9(1):34-7. PubMed ID: 23691452
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
20. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]